Harvard Bio Shares Slide 10.82 Percent as Revenue Inches Higher and Loss Turns to Profit

May 06, 2005

NEW YORK, May 6 (GenomeWeb News) -- Shares of Harvard Bioscience were down 10.82 percent, or $.42, at $3.46 in mid-afternoon trading after the company yesterday reported a 1-percent increase in revenues and a small net profit for the first quarter of 2005.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Pathogen Tracking

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.

Teeny Tiny DNA Robot

Popular Mechanics reports that Caltech researchers have built a prototype nanobot using DNA.

New Siblings

The Sacramento Bee writes that direct-to-consumer genetic testing connected a woman to sperm donor-conceived half siblings.

This Week in PLOS

In PLOS this week: gene expression catalog for sheep, viral diversity among respiratory samples from camels, and more.

Main menu